Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABAL.L Regulatory News (ABAL)

  • There is currently no data for ABAL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Equity

8 Feb 2012 07:00

RNS Number : 9954W
Imaginatik PLC
08 February 2012
 

8 February 2012

 

 

Imaginatik Plc

("Imaginatik" or "the Company")

Issue of Equity

 

Imaginatik plc (AIM:IMTK), a leading provider of enterprise innovation services including a range of technology products and consultancy, is pleased to announce that following demand from certain existing and new investors, 85,505,352 new ordinary shares of 0.0625p each in the Company ("Subscription Shares") have been subscribed for at a price per share of 0.3 pence (the "Subscription Price"), to raise £256,516 before expenses. The Company intends that the net proceeds of the issue will be used for working capital purposes.

 

Application has been made for the new Shares to be admitted to trading on AIM, and dealings in the Subscription Shares are expected to commence at 8.00 a.m. on 13 February 2012 ("Admission"), following which the Company will have 513,032,110 Ordinary Shares in issue. This figure may be used by shareholders, from Admission, as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FSA's Disclosure and Transparency Rules.

 

The Directors named below have subscribed for Subscription Shares as set out below at the Subscription Price:

 

 

Name of Director

Number of Subscription Shares

 

conditionally subscribed for

Simon Charles

3,284,270

Matt Cooper

22,327,693

David Gammon

7,442,564

Brian Hays

954,175

Shawn Taylor

893,108

 

Each Directors' interests in Ordinary Shares in the Company is accordingly as follows:

 

Name of Director

Ordinary Shares held legally or beneficially

Options to subscribe for new Ordinary Shares

Agreement to subscribe for Subscription Shares

Aggregate interests in Ordinary Shares at Admission

Aggregate percentage of issued share capital at Admission

Simon Charles

8,702,501

-

3,284,270

11,986,771

2.34

Matt Cooper

32,811,922

3,125,000

22,327,693

58,264,615

11.36

David Gammon

5,000,000

-

7,442,564

12,442,564

2.43

Nick Goss

-

-

-

-

-

Brian Hays

6,000,000

-

954,175

6,954,175

1.36

Luis Solis

-

4,000,000

-

4,000,000

0.78

Shawn Taylor

5,712,192

6,200,000

893,108

12,805,300

2.50

 

 

The interests of Mr Gammon set out above in ordinary shares include those of his wife, Sarah Gammon.

 

The aggregate subscription by the Directors (the "Directors' Participations") constitutes a related party transaction for the purposes of the AIM Rules. Luis Solis, the Director who is deemed to be independent for the purposes of this participation in the subscription, considers, having consulted with Northland Capital Partners Limited as the Company's nominated adviser, that the terms of the Directors' Participations are fair and reasonable insofar as Shareholders are concerned.

Executive Chairman of Imaginatik, Matt Cooper, commented, "We have taken significant strides forward in recent months, strengthening our team, investing in our technology products and services and securing some of the world's largest businesses as customers. We are delighted that this progress has resulted in increased interest from employees and investors to fund the Company. Imaginatik is in a strong position, with a good sales pipeline and a motivated team and we continue to be focused on delivering the positive results our shareholders deserve."

For further information please contact:

Imaginatik plc

Tel: 020 7917 2975

Matt Cooper, Executive Chairman / Shawn Taylor, CFO

 

 

 

Northland Capital Partners Limited

Tel: 020 7796 8800

Gavin Burnell / Edward Hutton

 

 

 

Newgate Threadneedle

Tel: 020 7653 9850

Caroline Evans-Jones / Hilary Millar

 

 

 

About Imaginatik

 

Imaginatik provides a range of Innovation solutions comprised of consultancy, enterprise software and program management to deliver innovation results to companies such as The World Bank, NYSE, The Chubb Group of Insurance Companies, Boeing, Pfizer, Goodyear, Paccar, Kellogg and Cargill. Few companies possess the internal capability to consistently generate fresh ideas, identify those worth pursuing and reliably transform them into real, value-enhancing assets. This is Imaginatik's area of expertise.

 

Imaginatik is a public company whose shares are traded on the AIM market of the London Stock Exchange (LSE:IMTK.L) and is a World Economic Forum Technology Pioneer with offices in Boston, MA, and Winchester, UK. For more information visit www.imaginatik.com.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEEAFAXESEAEAF
Date   Source Headline
19th Dec 20083:16 pmRNSDirector/PDMR Shareholding
18th Dec 20089:45 amRNSDirector/PDMR Shareholding
17th Dec 20087:00 amRNSShare Option Schemes
1st Dec 20087:00 amRNSDirector's Disclosure Update
19th Nov 200812:39 pmRNSDirectors Dealing
13th Nov 20087:00 amRNSInterim Results
14th Oct 20087:00 amRNSTrading Statement
2nd Oct 20087:00 amRNSContract Win
30th Sep 20084:30 pmRNSTotal Voting Rights
24th Sep 20087:00 amRNSDirector/PDMR Shareholding
15th Sep 20087:00 amRNSContract Win
3rd Sep 20087:00 amRNSIssue of Equity
21st Aug 20087:00 amRNSContract Win
28th Jul 20089:27 amRNSNon-Executive Retirement
10th Jul 200810:20 amRNSResult of AGM
10th Jul 20087:00 amRNSAGM Statement
24th Jun 20087:00 amRNSDirector/PDMR Shareholding
18th Jun 200810:05 amRNSAnnual Report and Accounts
13th Jun 200812:16 pmRNSDirector/PDMR Shareholding
11th Jun 20087:00 amRNSFinal Results
1st Apr 200811:52 amRNSDirector Dealings
31st Mar 20084:30 pmRNSTotal Voting Rights
17th Mar 20082:57 pmRNSShare Subscription - Update
10th Mar 20082:23 pmRNSShare Subscription
10th Mar 20089:30 amRNSHolding(s) in Company
28th Feb 200810:01 amRNSPfizer Update
13th Feb 20089:40 amRNSTrading Statement
22nd Jan 20089:30 amRNSWorld Economic Forum
11th Jan 200810:13 amRNSMajor Contract Wins
30th Nov 20072:41 pmRNSWEF Technology Pioneer
14th Nov 20072:12 pmRNSInterim Results
16th Aug 200711:05 amRNSAgreement With IBM
14th Aug 20074:55 pmRNSAIM Rule 26 Information
27th Jul 200710:46 amRNSAGM Statement
27th Jul 20077:01 amRNSAGM Statement
11th Jul 200712:00 pmBUSGlobal Competition Forces Innovation and Collaboration Acceleration
29th Jun 20073:33 pmRNSAnnual Report and Accounts
13th Jun 200711:50 amRNSResult of EGM
12th Jun 20077:02 amRNSFinal Results
4th Jun 20077:02 amRNSUK & European Contract Wins
1st Jun 200710:29 amRNSNotice of Results
18th May 200710:05 amRNSNotice of EGM
23rd Apr 20072:38 pmBUSImaginatik Wins a Queens Award for Enterprise
23rd Apr 200711:02 amRNSWins A Queens Award
19th Apr 200710:59 amRNSDirector/PDMR Shareholding
21st Mar 20077:04 amRNSSenior Management Appointment
21st Mar 20077:01 amBUSImaginatik Appoints President, Americas and New CMO to Accommodate Growth
16th Mar 200711:45 amRNSTrading Statement
9th Feb 200711:30 amBUSImaginatik Appoints Managing Director in United Kingdom
9th Feb 20077:00 amRNSAppointment of UK MD

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.